心脏房室 incidental 剂量未改善晚期非小细胞肺癌 IMRT 后放射性肺炎预测
本研究评估心脏心房和心室 incidental 辐射剂量是否改善接受 IMRT 或 VMAT 治疗的晚期非小细胞肺癌患者≥3级放射性肺炎的预测。188例患者中26例(13.8%)发生放射性肺炎,仅平均肺剂量(MLD)在组间有差异(15.3 Gy vs 13.7 Gy,P=.004),MLD 的 Spearman 相关系数最高(Rs=0.21,P<.01),心脏 DVH 参数很少被纳入预测模型。结论:心脏 incidental 剂量未改善放射性肺炎风险预测。
要点
- 188例晚期 NSCLC 患者中13.8%发生≥3级放射性肺炎。
- 仅 MLD 在放射性肺炎组与非放射性肺炎组间有差异(P=.004)。
- 心脏 DVH 参数很少被纳入放射性肺炎预测模型。
核心结论
- 心脏心房和心室的 incidental 剂量未改善接受 IMRT 或 VMAT 治疗的晚期非小细胞肺癌患者的放射性肺炎风险预测。
研究设计与样本
- 采用 bootstrap 建模方法,评估188例接受 IMRT 或 VMAT 治疗的晚期非小细胞肺癌患者的临床参数及肺和心脏(心房、心室分别及联合评估)的剂量体积直方图参数对放射性肺炎的预测价值。
主要发现
- 中位随访18.4个月后,26例患者(13.8%)发生≥3级放射性肺炎。
- 仅中位平均肺剂量在放射性肺炎组与非放射性肺炎组间有差异(15.3 Gy vs 13.7 Gy,P=.004)。
- MLD 对放射性肺炎的 Spearman 相关系数最高(Rs=0.21,P<.01)。
- 多数肺 DVH 参数的 Spearman 相关系数高于心脏 DVH 参数。
- bootstrap 预测建模中,MLD 始终被纳入≥3级放射性肺炎预测模型,而心脏 DVH 参数很少被纳入。
临床怎么用
- 在晚期非小细胞肺癌 IMRT 或 VMAT 计划评估中,MLD 仍是放射性肺炎风险预测的重要剂量学参数,心脏 incidental 剂量不改善预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate whether inclusion of incidental radiation dose to the cardiac atria and ventricles improves the prediction of grade ≥3 radiation pneumonitis (RP) in advanced-stage non-small cell lung cancer (AS-NSCLC) patients treated with intensity modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT). METHODS AND MATERIALS: Using a bootstrap modeling approach, clinical parameters and dose-volume histogram (DVH) parameters of lungs and heart (assessing atria and ventricles separately and combined) were evaluated for RP prediction in 188 AS-NSCLC patients. RESULTS: After a median follow-up of 18.4 months, 26 patients (13.8%) developed RP. Only the median mean lung dose (MLD) differed between groups (15.3 Gy vs 13.7 Gy for the RP and non-RP group, respectively; P=.004). The MLD showed the highest Spearman correlation coefficient (Rs) for RP (Rs = 0.21; P<.01). Most Rs of the lung DVH parameters exceeded those of the heart DVH parameters. After predictive modeling using a bootstrap procedure, the MLD was always included in the predictive model for grade ≥3 RP, whereas the heart DVH parameters were seldom included in the model. CONCLUSION: Incidental dose to the cardiac atria and ventricles did not improve RP risk prediction in our cohort of 188 AS-NSCLC patients treated with IMRT or VMAT.
引用
- Wijsman R, Dankers FJWM, Troost EGC, et al. Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017. PMID: 28871994. doi:10.1016/j.ijrobp.2017.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。